iifl-logo-icon 1

Ajanta Pharma Ltd Dividend

2,775.95
(-2.06%)
Jan 13, 2025|03:31:04 PM

Ajanta Pharma CORPORATE ACTIONS

14/01/2024calendar-icon
13/01/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend28 Oct 20246 Nov 20246 Nov 2024281400Interim 1
We hereby inform that the Board at the Board meeting held on Monday, 28th October 2024, has inter-alia approved the Unaudited (Consolidated & Standalone) Financial Results of the Company for the quarter and half year ended 30.09.2024 and declared 1st interim dividend for FY 2025. PFA enclosed outcome of Board Meeting for more details.
Dividend31 Jan 20248 Feb 20248 Feb 2024261300Interim 2
The Board in its meeting held today has approved 2nd Interim Dividend. For more details please find enclosed herewith outcome of the Board Meeting.

Ajanta Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.